Liren Hu
- Topics
- Cancer, Hypoxia, and Metabolism (2 papers)RNA modifications and cancer (2 papers)Bacterial Identification and Susceptibility Testing (2 papers)
- Journals
- PLoS ONEScientific ReportsMedicine
- Partner nations
- ChinaUnited KingdomTürkiye
In The Last Decade
Liren Hu
19 papers receiving 430 citations
Peers
Comparison fields: 5 of 93
- Molecular Biology 159
- Epidemiology 121
- Cancer Research 104
- Oncology 85
- Surgery 69
Countries citing papers authored by Liren Hu
This map shows the geographic impact of Liren Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liren Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liren Hu more than expected).
Fields of papers citing papers by Liren Hu
This network shows the impact of papers produced by Liren Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liren Hu. The network helps show where Liren Hu may publish in the future.
Co-authorship network of co-authors of Liren Hu
This figure shows the co-authorship network connecting the top 25 collaborators of Liren Hu. A scholar is included among the top collaborators of Liren Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liren Hu. Liren Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 5 | |
| 4 | 28 | |
| 5 | 17 | |
| 6 | 19 | |
| 7 | 9 | |
| 8 | 36 | |
| 9 | 64 | |
| 10 | 12 | |
| 11 | 45 | |
| 12 | 116 | |
| 13 | Association of heme oxygenase-1 polymorphisms with cancer risk: A systematic review and meta-analysis. | 8 |
| 14 | 15 | |
| 15 | Prognostic value of rsf-1/hbxap in human solid tumors: a meta-analysis of cohort studies. | 4 |
| 16 | 15 | |
| 17 | 14 | |
| 18 | Tumor suppressor TSLC1 inhibits growth, proliferation, invasiveness and angiogenesis in nude mice xenografted tumor of Eca109 cells. | 3 |
| 19 | 9 | |
| 20 | 16 |
About Liren Hu
Liren Hu is a scholar working on Otorhinolaryngology, Clinical Biochemistry and Cancer Research, having authored 20 papers that have together received 437 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (2 papers), RNA modifications and cancer (2 papers) and Bacterial Identification and Susceptibility Testing (2 papers). The work is most often cited by research in Cancer Research (104 citations), Critical Care and Intensive Care Medicine (25 citations) and Otorhinolaryngology (21 citations). Liren Hu has collaborated with scholars based in China, United Kingdom and Türkiye. Frequent co-authors include Jiayuan Wu, Taiping He, Gaohua Zhang, Lei Zou, Haiqing Luo, Wenjun Cao, Manyu Chen, Na Yao, Liquan Chen and Zhan‐Hui Zhang. Their work appears in journals such as PLoS ONE, Scientific Reports and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.